Kaiser Permanente 3-year study is one of the longest to study high-risk patients managing diabetes with continuous glucose monitors.

Kaiser Permanente 3-year study is one of the longest to study high-risk patients managing diabetes with continuous glucose monitors. New study also highlights need to increase awareness of trials ...

Shannon N. Ogden, PhD, MPH, is a Postdoctoral Research Fellow at the Kaiser Permanente Division of Research. Dr. Ogden’s research interests lie in the implementation and evaluation of policies and ...

BACKGROUND: Prelicensure clinical studies may not include sufficient numbers of subjects to assess the potential for rare postvaccination adverse events. The aim of this postlicensure study ...

One-year review of ambient scribe technology at The Permanente Medical Group finds evidence it could reduce documentation burden A year into the rollout of a generative artificial intelligence (AI) ...

New diagnoses of cannabis use disorder (CUD) among adolescents in Northern California began climbing after recreational cannabis was legalized in California in 2016, reversing a steady decline in the ...

The vaccine currently used to protect people against shingles maintains strong effectiveness over 4 years post-vaccination, according to a Kaiser Permanente-led research study published in Annals of ...

Clinical documentation in the electronic health record (EHR) has become increasingly burdensome for physicians and is a major driver of clinician burnout and dissatisfaction. Time dedicated to ...

Kaiser Permanente study identifies factors that could help doctors determine which patients are most likely to achieve this goal A diagnosis of type 2 diabetes typically means a future of blood sugar ...

A follow-up program for Kaiser Permanente Northern California (KPNC) patients discharged from the hospital was associated with reduced readmissions without increased mortality, new research in the ...

Kaiser Permanente vaccine researchers report long-term study of Zostavax, no longer used in U.S. The original vaccine against shingles — Zostavax, a live shingles vaccine no longer used in the U.S. — ...

Kaiser Permanente Northern California’s life-saving Advance Alert Monitor (AAM) program — an early detection system that helps care teams predict when hospitalized patients are at risk for clinical ...